References
- Carr BR. Disorders of the ovary and female reproductive tract. In: Wilson JD, Foster DW, eds. Williams textbook of endocrinology. 8th ed. Philadelphia: Saunders, 1992: 733–98
- Lobo RA. Androgen excess. In: Mishell DR Jr, Davajan V, Lobo RA, eds. Infertility, contraception & reproductive endocrinology. 3d ed. Boston: Blackwell Scientific, 1991: 442–6
- Horton H, Hawks D, Lobo R. 3α, 17 ß -androstanediol glucuronide in plasma: a marker of androgen action in idiopathic hirsutism. J Ciin Invest 1982; 69(5): 1203–6
- Serafini P, Ablan F, Lobo RA. 5alpha; -reductase activity in the genital skin of hirsute women. J Clin Endocrinol Metab 1985; 60(2): 349–55
- Rebar RVR Hirsutism, hyperandrogenism, and polycystic ovarian syndrome. In: DeGroot L.J, Besser GM, Cahill GF Jr, et al, eds. Endocrinology. 2d ed. Philadelphia: Saunders, 1989: 1982–93
- Barbieri RL, Smith S, Ryan KJ. The role of hyperinsulmemia in the padiogenesis of ovarian hyperandrogenism. Fertil Steril 1988; 50(2): 197–212
- Morris M. Virilizing tumors of the ovary. Cancer Bull 1987; 39: 300–3
- Scully RE. Ovarian tumors with endocrine manifestations. In: DeGroot et al, eds,5 pp 1994–2008
- McClamrock HD, Adashi EY. Gestational hyperandrogenism. Fertil Steril 1992; 57(2): 257–74
- White PC, New MI, Dupont B. Congenital adrenal hyperplasia. N Engl] Med 1987; 316(24): 1519–24
- Kutternn F, Couillin P, Girard F, et al. Late-onset adrenal hyperplasia in hirsutism. N Engl j Med 1985; 313(4): 224–31
- Speiser PW, Dupont B, Rubinstein P, et al. High frequency of nonclassical steroid 21-hydroxylase deficiency. Am J Hum Genet 1985; 37(4): 650–67
- Karpas AE. Iatrogenic hirsutism. In: Greenblatt RB, Mahesh VB, Gambrell RD, eds. The cause and management of hirsutism: a practical approach to the control of unwanted hair. Park Ridge, NJ: Parthenon Pub Group, 1987: 61–9
- Thomas PK, Ferriman DG. Variation in facial and pubic hair growth in white women. Am J Phys Anthrop 1957; 15(2): 171–80
- Frisch RE. Body weight, body fat and ovulation. Trends Endocrinol Metab 1991; 2: 191–7
- Rebar KW, Zeserson K. Characteristics of the new progestogens in combination oral contraceptives. Contraception 1991; 44(1): 1–10
- Menard RH, Guenthner TM, Kon H, et al. Studies on the destruction of adrenal and testicular cytochrome P-450 by spironolactone: requirement for the 7 alpha-thio group and evidence for the loss of the heme and apoproteins of cytochrome P-450. J Biol Chem 1979; 254(5): 1726–33
- Corral P, Michand A, Menard J, et al. Antiandrogenic effect of spironolactones: mechanism of action. Endocrinology 1975; 97(1): 52–8